ACCG-2671 is an oral small molecule amylin receptor agonist which acts through complementary satiety pathways in the ...
Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ...
Structure Therapeutics' Phase 2 data for Aleniglipron show 16% weight loss at 44 weeks with strong tolerability and no safety signals. Read more on GPCR stock.
Structure Therapeutics (NasdaqGM:GPCR) reported positive topline Phase 2 results for its oral GLP-1 receptor agonist ...
Maddie Lightening shares lessons from a currency reporting error and legacy account structure challenges, and using AI ...
The "Oil Refining Industry in Iraq 2026" has been added to ResearchAndMarkets.com's offering. This comprehensive report provides critical insights into Iraq's crude oil refining industry, offering ...
A C-suite executive retiring at 62 with $1.8 million in a traditional 401(k), $400,000 in RSUs, a nonqualified deferred ...
The Value Operator is an orchestrator who centrally owns contract translation, governance, data configuration, and ...
Elk Marketing reports that structured data enhances AI understanding, enabling accurate entity recognition and improved ...
New report maps the global ultrasound ecosystem from $12.5B (2024A) to $21.5B (2035E) and explains how value shifts to ...
At first glance, Lamine Yamal’s role in FC Barcelona’s attack seems rather simple. He receives wide on the right, dribbles ...
By Nora Buli and Emily Chow OSLO/SINGAPORE, March 27 (Reuters) - Russia's threat to halt liquefied natural gas (LNG) ...